Navigation Links
Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance
Date:3/2/2011

s compared to the previously provided range of $45 million to $48 million.

Additional details will be provided during the upcoming conference call and in an investor presentation summarizing the company's fiscal year 2011 third quarter results, which is available in the investor relations section of Cyberonics' corporate website at http://www.cyberonics.com.

Fiscal Year 2011 Third Quarter Results Conference Call InstructionsCyberonics will host a conference call today, March 2, 2011, beginning at 7:30 a.m. Central Time (8:30 a.m. Eastern Time) to review its results of operations for the third quarter of fiscal 2011 and future outlook, followed by a question and answer session.

The conference call will be available to interested parties through a live audio webcast in the investor relations section of Cyberonics' corporate website at http://www.cyberonics.com, where it will be archived and accessible for approximately 12 months.  To listen to the conference call live by telephone dial 877-638-4557 (if dialing from within the U.S.) or 914-495-8522 (if dialing from outside the U.S.).  The conference ID is 43242663.

A replay of the conference call will be available approximately two hours after the completion of the conference call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing from outside the U.S.).  The replay conference ID access code is 43242663.  The replay will be available for one week on the above number.

About Cyberonics, Inc. and the VNS Therapy® SystemCyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical devic
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cyberonics Provides Update on Depression Post-Approval Study
2. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results
3. Cyberonics Provides Update on Tax Position
4. Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference
5. Cyberonics Announces Epilepsy Technology Agreements
6. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
7. Cyberonics to Participate in Upcoming September Investor Conferences
8. Cyberonics Reports Inducement Equity Awards Under NASDAQ Listing Rule 5635(c)(4)
9. Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results
10. Cyberonics to Present at 22nd Annual Piper Jaffray Health Care Conference
11. Cyberonics to Report Fiscal Year 2011 Third Quarter Results and Host Conference Call on March 2, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... YORK , May 26, 2015  Delcath ... Jennifer Simpson , Ph.D., M.S.N., C.R.N.P. has ... the Company,s Board of Directors, effective immediately.  Dr. ... Executive Officer of Delcath since September 2014 and ... September 2013 to September 2014.  She joined Delcath ...
(Date:5/26/2015)... 2015 ViiV Healthcare, Aurobindo Pharma, ... today that Aurobindo Pharma has submitted an Abbreviated New ... to the Food and Drug Administration (FDA), for the ... a generic version of dolutegravir, less than two years ... the United States . ...
(Date:5/26/2015)... May 26, 2015 Sanomedics, Inc. (OTC: SIMH) ... has expanded into the fast growing behavioral health sector ... is a developmental stage, Software as a Services (SaaS) ... addiction treatment service and care centers. ... to enter the nascent behavioral health sector where the ...
Breaking Medicine Technology:Delcath Names Dr. Jennifer Simpson President And CEO 2Delcath Names Dr. Jennifer Simpson President And CEO 3Delcath Names Dr. Jennifer Simpson President And CEO 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 2Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 3
... (Nasdaq: BCRX ) today announced preliminary results ... administered via a single,dose injection in the outpatient ... conducted by BioCryst,s partner, Shionogi & Co., Ltd.,in ... the median time to,alleviation of symptoms in subjects ...
... Higher then Expected MCI Prevalence Shows Urgent Need ... Two studies related to,experimental Alzheimer,s therapies reported positive ... on Alzheimer,s,Disease (ICAD 2008) in Chicago., One ... targeted early,abnormal brain changes in a protein called ...
Cached Medicine Technology:BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 2BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 3BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 4BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 5Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 2Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 3Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 4Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 5Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets 6
(Date:5/26/2015)... Beloved local Arizona company, Parker and Sons, ... drain clog guarantee or else its free. , Parker ... found here . What’s more, Parker and Sons offers ... in the company’s rich legacy, and immense success. , ... drain clog imaginable. Whether it be low water flow or ...
(Date:5/26/2015)... May 26, 2015 Last week, ... Mexico patients with MRI, Ultrasound, and CT services—was ... American College of Radiology. The center is now ... , In order to be eligible for ... of qualifications including personnel qualifications, adequacy of facility ...
(Date:5/26/2015)... May 26, 2015 Marching bands ... summer season, and thanks to the efforts of ... more of their musicians are protecting their hearing ... over 400 participating groups, Etymotic’s Adopt-a-Band program continues ... Etymotic are now for sale in drum shops ...
(Date:5/26/2015)... It was an evening befitting the largest, oldest, ... May 13, The Denver Foundation marked 90 years of ... giving with its Annual Celebration, held at the Seawell ... event celebrated the donors, leaders, grantees, and volunteers who ... good. , “If your organization, neighborhood group, or cause ...
(Date:5/26/2015)... Baltimore, MD (PRWEB) May 26, 2015 ... of marijuana. According to an article published by ... 2015 synthetic marijuana (dubbed K2, Spice, and black ... unstable composition of these synthetic substances make it ... and confirm patients’ use of the substance due ...
Breaking Medicine News(10 mins):Health News:Parker and Sons Offers Special, Sixty Minute Drain Clean Guarantee or Else It’s on Them 2Health News:Marching Musicians Getting In Step With Hearing Protection 2Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3
... strain of laboratory mice that has "superhealing" powers has ... and also to avoid developing arthritis at the injury ... Duke University Medical Center. Their findings illuminate the mechanisms ... this condition, which commonly afflicts younger people who lose ...
... as Part of 2009 Amgen Tour of California Cycling ... The Patient Advocate Foundation (PAF) - a national non-profit ... of patients every year who are unable to obtain ... - is pleased to partner with Breakaway from ...
... Jackman, and Robert Downey, Jr., to be Auctioned at ... Services CharityNEW YORK, Feb. 22 On the morning ... delighted to announce a symbolic charitable donation to mark ... the Oscars(R). The esteemed champagne house is honored to ...
... AT&T*, the only wireless,carrier that lets Philadelphia subway ... has expanded its wireless network coverage,along the Broad ... Operated by the Southeastern Pennsylvania Transportation Authority,(SEPTA), the ... than 150,000 daily,riders accessing stops at City Hall ...
... begun to solve some of the mysteries of the ... genetic codes for all the known strains of the ... of Medicine in Baltimore and colleagues at the University ... viruses and assembled them into a "family tree," which ...
... and pain fell for participants, study finds , , SATURDAY, Feb. ... way to treat the lower leg pain and cramping caused ... Dutch study, published in the February issue of the ... type of leg pain that occurs while walking, known as ...
Cached Medicine News:Health News:New clues to healing arthritis caused by traumatic injury 2Health News:New clues to healing arthritis caused by traumatic injury 3Health News:Patient Advocate Foundation Partners with Breakaway from Cancer, Raising Awareness and Funds for Free Services Available to Cancer Patients 2Health News:Patient Advocate Foundation Partners with Breakaway from Cancer, Raising Awareness and Funds for Free Services Available to Cancer Patients 3Health News:Moet & Chandon Releases Grand Vintage 1929 Magnum Commemorating First-Ever Academy Awards(R) To Benefit Motion Picture & Television Fund 2Health News:Moet & Chandon Releases Grand Vintage 1929 Magnum Commemorating First-Ever Academy Awards(R) To Benefit Motion Picture & Television Fund 3Health News:Moet & Chandon Releases Grand Vintage 1929 Magnum Commemorating First-Ever Academy Awards(R) To Benefit Motion Picture & Television Fund 4Health News:AT&T Expands Wireless Coverage on Broad Street Line of SEPTA 2Health News:AT&T Expands Wireless Coverage on Broad Street Line of SEPTA 3Health News:Researchers crack the code of the common cold 2Health News:Researchers crack the code of the common cold 3Health News:Researchers crack the code of the common cold 4Health News:Walking Program May Relieve Peripheral Artery Pain 2
Prevents contamination of RNA experiments commonly caused by latex gloves; made of Nitrile; these gloves are also certified free of Dnase...
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
... 8000 retracting base sliding microtome offers the ... reliability and, not least, safety. ,Designed to ... laboratory, the 8000 will also meet the ... where its versatility and wide range of ...
... Leica VT1000 S is a vibrating blade ... to meet the highly sophisticated sectioning requirements ... neurophysiology, neuropathology and experimental (brain) research ... and some industrial applications related to structural ...
Medicine Products: